THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Artificial heart's use marks milestone

Commercial implant is a first for Abiomed's self-contained device

AbioCor is considered self-contained because it has a built-in battery. AbioCor is considered self-contained because it has a built-in battery.
By Robert Weisman
Globe Staff / June 25, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

A self-contained artificial heart made by Abiomed Inc., a Danvers cardiac device company, has been successfully implanted in a patient at Robert Wood Johnson University Hospital in New Brunswick, N.J., marking the first commercial implantation of the device. (Full article: 628 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass